IRRAS
ISIN: SE0008321202 | Ticker: IRRAS | LEI: 549300EKKVQN2J25MJ59
Country: Sweden
Founded in Sweden in 2012, IRRAS is a commercial medical device company, focused on designing, developing, and commercializing innovative solutions that transform fluid management after surgical procedures. Our initial clinical focus is on intracranial procedures, where excess cerebrospinal fluid (CSF) often needs to be drained and intracranial pressure (ICP) needs to be closely regulated.
IRRAS’ first commercial product, IRRAflow®, is a next generation intracranial fluid exchange system that consists of a patented dual lumen catheter and control unit with proprietary software that work together to manage the drainage of excess fluid, intelligently manage the regulation of the patient’s ICP, and, on a regular basis, proactively flush the catheter to prevent occlusions from forming.
2012
Served areaEurope and USA
HeadquartersVasagatan 16, 11120 Stockholm – Sweden
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Assets | N/A | 209,035,000.00 | 132,594,000.00 | 171,618,000.00 |
| Noncurrent Assets | N/A | 44,914,000.00 | 39,790,000.00 | 34,785,000.00 |
| Property Plant And Equipment | N/A | 1,310,000.00 | 1,103,000.00 | 1,860,000.00 |
| Intangible Assets Under Development | N/A | 33,294,000.00 | 28,592,000.00 | 20,321,000.00 |
| Current Assets | N/A | 164,121,000.00 | 92,804,000.00 | 136,833,000.00 |
| Inventories | N/A | 18,074,000.00 | 12,368,000.00 | 29,144,000.00 |
| Current Trade Receivables | N/A | 5,056,000.00 | 16,262,000.00 | 29,407,000.00 |
| Current Advances To Suppliers | N/A | 2,865,000.00 | 1,007,000.00 | N/A |
| Other Current Receivables | N/A | 1,292,000.00 | 1,631,000.00 | 8,956,000.00 |
| Cash and cash equivalents | 29,514,000.00 | 135,604,000.00 | 55,855,000.00 | 69,259,000.00 |
| Current Investments | N/A | 0.00 | 0.00 | 0.00 |
| Equity And Liabilities | N/A | 209,035,000.00 | 132,594,000.00 | 171,618,000.00 |
| Equity | 131,470,000.00 | 182,353,000.00 | 111,633,000.00 | 146,043,000.00 |
| Issued Capital | N/A | 1,988,000.00 | 2,384,000.00 | 23,844,000.00 |
| Retained Earnings | N/A | -540,023,000.00 | -675,132,000.00 | -840,998,000.00 |
| Other Reserves | N/A | -6,281,000.00 | -3,430,000.00 | -2,317,000.00 |
| Additional Paidin Capital | N/A | 726,668,000.00 | 787,811,000.00 | 965,513,000.00 |
| Noncurrent Provisions | N/A | 76,000.00 | 161,000.00 | 5,920,000.00 |
| Current Liabilities | N/A | 26,607,000.00 | 20,800,000.00 | 19,655,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 3,450,000.00 | 5,459,000.00 | 7,085,000.00 |
| Current Accruals And Current Deferred Income Including Current Contract Liabilities | N/A | N/A | 9,403,000.00 | 11,445,000.00 |
| Other Current Liabilities | N/A | 7,329,000.00 | 2,423,000.00 | 701,000.00 |
| Line item in (sek) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|
| Revenue | 7,390,000.00 | 22,386,000.00 | 39,998,000.00 |
| Other Income | 1,594,000.00 | 8,097,000.00 | 658,000.00 |
| Profit Loss From Operating Activities | -134,316,000.00 | -136,522,000.00 | -168,090,000.00 |
| Finance Income | 8,000.00 | 299,000.00 | 2,275,000.00 |
| Finance Costs | 1,596,000.00 | 112,000.00 | 765,000.00 |
| Profit Loss Before Tax | -135,903,000.00 | -136,335,000.00 | -166,580,000.00 |
| Income Tax Expense Continuing Operations | 12,000.00 | 0.00 | 24,000.00 |
| Profit (loss) | -135,916,000.00 | -136,335,000.00 | -166,604,000.00 |
| Line item in (sek) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|
| Profit (loss) | N/A | -135,916,000.00 | -136,335,000.00 | -166,604,000.00 |
| Adjustments For Decrease Increase In Inventories | N/A | -6,177,000.00 | 1,970,000.00 | -29,157,000.00 |
| Adjustments For Depreciation And Amortisation Expense | N/A | 16,326,000.00 | 16,819,000.00 | 17,302,000.00 |
| Adjustments For Sharebased Payments | N/A | -361,000.00 | 1,195,000.00 | 625,000.00 |
| Other Adjustments For Noncash Items | N/A | 0.00 | -1,923,000.00 | 14,559,000.00 |
| Interest Paid Classified As Operating Activities | N/A | 378,000.00 | 151,000.00 | 602,000.00 |
| Interest Received Classified As Operating Activities | N/A | 8,000.00 | 1,000.00 | 0.00 |
| Cash Flows From Used In Operating Activities | N/A | -132,693,000.00 | -130,540,000.00 | -175,835,000.00 |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 882,000.00 | 565,000.00 | 1,361,000.00 |
| Purchase Of Intangible Assets Classified As Investing Activities | N/A | 7,795,000.00 | 6,707,000.00 | 2,083,000.00 |
| Cash Flows From Used In Investing Activities | N/A | 46,788,000.00 | -7,272,000.00 | -3,444,000.00 |
| Proceeds From Issuing Shares | N/A | 217,288,000.00 | 66,000,000.00 | 214,600,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | 6,813,000.00 | 0.00 | 0.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 3,786,000.00 | 4,320,000.00 | 5,165,000.00 |
| Cash Flows From Used In Financing Activities | N/A | 193,433,000.00 | 57,219,000.00 | 193,997,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 107,529,000.00 | -80,593,000.00 | 14,718,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -1,439,000.00 | 844,000.00 | -1,314,000.00 |
| Cash and cash equivalents | 29,514,000.00 | 135,604,000.00 | 55,855,000.00 | 69,259,000.00 |
Please note that some sums might not add up.
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 13.10.23 | Marios Fotiadis | Other | Other | SEK 60,887,671.20 |
| 18.09.23 | Marios Fotiadis | Other | Buy | SEK 1,653,362.28 |
| 04.09.23 | MARIOS FOTIADIS | Other | Sell | SEK 229,986.00 |
| 11.06.21 | Bacara Holdings Limited | Other | Other | SEK 17,500,000.00 |
| 11.06.21 | Kleanthis Xanthopoulos | Other | Other | SEK 1,000,000.00 |
| 04.05.21 | Sabina Berlin | Other | Buy | SEK 49,997.52 |
| 24.09.20 | Carl Martin | Other | Buy | SEK 99,950.55 |
| 22.09.20 | Carl Martin | Other | Buy | SEK 33,365.09 |
| 09.04.20 | Anders Paul Wiklund | Other | Other | SEK 99,377.20 |
| 09.04.20 | Sabina Berlin | Other | Other | SEK 42,224.00 |
SE0008321202
LEI549300EKKVQN2J25MJ59
SectorHealth Care Equipment & Services
IndustryHealth Care Equipment & Supplies
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.